1. Home
  2. DYAI vs SRXH Comparison

DYAI vs SRXH Comparison

Compare DYAI & SRXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • SRXH
  • Stock Information
  • Founded
  • DYAI 1979
  • SRXH 2013
  • Country
  • DYAI United States
  • SRXH Canada
  • Employees
  • DYAI N/A
  • SRXH N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • SRXH
  • Sector
  • DYAI Health Care
  • SRXH
  • Exchange
  • DYAI Nasdaq
  • SRXH NYSE
  • Market Cap
  • DYAI 28.3M
  • SRXH 7.4M
  • IPO Year
  • DYAI 2004
  • SRXH N/A
  • Fundamental
  • Price
  • DYAI $1.00
  • SRXH $0.53
  • Analyst Decision
  • DYAI Strong Buy
  • SRXH
  • Analyst Count
  • DYAI 1
  • SRXH 0
  • Target Price
  • DYAI $6.00
  • SRXH N/A
  • AVG Volume (30 Days)
  • DYAI 63.2K
  • SRXH 555.8K
  • Earning Date
  • DYAI 08-12-2025
  • SRXH 05-15-2025
  • Dividend Yield
  • DYAI N/A
  • SRXH N/A
  • EPS Growth
  • DYAI N/A
  • SRXH N/A
  • EPS
  • DYAI N/A
  • SRXH N/A
  • Revenue
  • DYAI $3,554,344.00
  • SRXH $119,421,918.00
  • Revenue This Year
  • DYAI $22.56
  • SRXH $26.28
  • Revenue Next Year
  • DYAI $30.95
  • SRXH $25.00
  • P/E Ratio
  • DYAI N/A
  • SRXH N/A
  • Revenue Growth
  • DYAI 57.59
  • SRXH 26.27
  • 52 Week Low
  • DYAI $0.91
  • SRXH $0.47
  • 52 Week High
  • DYAI $2.20
  • SRXH $4.25
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 46.85
  • SRXH N/A
  • Support Level
  • DYAI $0.91
  • SRXH N/A
  • Resistance Level
  • DYAI $1.02
  • SRXH N/A
  • Average True Range (ATR)
  • DYAI 0.05
  • SRXH 0.00
  • MACD
  • DYAI 0.01
  • SRXH 0.00
  • Stochastic Oscillator
  • DYAI 35.07
  • SRXH 0.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About SRXH SRX HEALTH SOLUTIONS INC

SRX HealthSolutions Inc is an integrated, Canadian healthcare service provider operating within the specialty healthcare industry. It has developed a collaborative specialty healthcare network (the SRx Network) that strategically positions SRx to achieve business objectives. The SRx Network is comprised of 29 specialty pharmacies, 40 infusion clinics and injection sites, four clinical trials sites, patient support programs (PSP), an allied health team and nursing services, and a wholly owned Health Canada-accredited pharmaceutical wholesale and distribution facility located in Mississauga, Ontario. The SRx Network extends across all 10 Canadian provinces, making it one of the accessible providers of comprehensive, integrated and customized specialty healthcare services in Canada.

Share on Social Networks: